Latest Bristol Myers Squibb News & Updates

See the latest news and media coverage for BMS. We track all announcements, press releases, and industry mentions in real time, all in one place.

Bristol Myers Squibb (BMS)

Global biopharmaceutical company

bms.com

Headquarters: Lawrence Township, United States
Company type: Public company
Number of employees: 35,000+
Industry: Pharmaceuticals

Last updated Today

Latest news about Bristol Myers Squibb (BMS)

In short: BMS raised its 2026 outlook following a strong Q2 earnings beat driven by Eliquis, while expanding its AI and manufacturing footprint.

Company announcements

July 30 BMS

Bristol Myers Squibb reports second quarter 2026 financial results

The company announced its Q2 2026 earnings and will host a conference call for investors at 8:15 a.m. ET.

July 20 BMS

BMS builds most powerful AI factory in life sciences with NVIDIA

The expanded collaboration gives BMS advanced NVIDIA DGX Vera Rubin systems to accelerate AI models and drug discovery.

July 13 BMS

BMS's FDA application for mezigdomide accepted

Based on SUCCESSOR-2 trial results showing improved progression-free survival in relapsed or refractory multiple myeloma.

June 2 BMS

BMS's iza-bren shows significant survival benefit in two cancers

The dual-targeted ADC met primary endpoints in two Phase 3 trials, showing statistically significant OS and PFS improvements.

Media coverage

July 31 The Pharma Letter

Bristol Myers lifts outlook as Eliquis drives Q2 earnings beat

US pharma major Bristol Myers Squibb has raised its full-year outlook after second-quarter 2026 revenue and earnings came in well above analyst expectations, helped by...

July 30 Seeking Alpha

BMS granted FDA review for label expansion of Merck-partnered anemia therapy

Bristol-Myers Squibb (BMY) has won FDA review for a marketing application seeking a label expansion for its Merck (MRK)-partnered anemia drug Reblozyl.

July 30 MSN

Gold surges 3%; Bristol-Myers Squibb earnings top views

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 200 points on Thursday. The Dow ...

July 30 BioSpace

BMS’ ‘big beat’ clouded by Cobenfy, heart disease data delays

Strong quarterly results are prompting Bristol Myers Squibb to lift its 2026 outlook, though the company is facing another delay for key Cobenfy Alzheimer’s data...

Never miss news about BMS

Track BMS and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

BMS competitors & trending companies

Browse news for competitors to BMS and other trending companies.